WS #10943

20:33→21:01 UTC
From 500 msgs · 6 key-dev

BridgeBio announces positive Phase 3 results for infigratinib in achondroplasia, plans NDA submission in Q3 2026.

BridgeBio Positive Trial Results

BridgeBio announces positive Phase 3 results for infigratinib in achondroplasia, plans NDA submission in Q3 2026.

Full world state #10943 →

Ukraine Drone Strikes on Russian RefineriesEuropean Heatwave Deaths
← WS #10942WS #10944 →
BearishNegativeNeutralPositiveBullish|ORDER: SIZE ▾↻ RESHUFFLE▸ LATER / NOW|